Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS)

scientific article published on 11 December 2014

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JTH.12778
P698PubMed publication ID25381723

P50authorChristine MannhalterQ21013476
Daniela DunklerQ54258757
Johannes ThalerQ61086802
Cihan AyQ66126625
P2093author name stringC Marosi
C Zielinski
I Pabinger
E-M Reitter
P2860cites workFamilial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein CQ24563608
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerQ33965106
Mutation in blood coagulation factor V associated with resistance to activated protein C.Q34340007
Venous thromboembolism and cancer: risks and outcomesQ35157800
Development and validation of a predictive model for chemotherapy-associated thrombosisQ36657982
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trialQ43284608
Malignancies, prothrombotic mutations, and the risk of venous thrombosisQ45249091
High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis studyQ45285047
The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosisQ46443827
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage studyQ48661559
Prediction of venous thromboembolism in cancer patients.Q51662626
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.Q51773327
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).Q53472586
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.Q53552275
Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer casesQ54401667
Clotting Factor Gene Polymorphisms and Colorectal Cancer RiskQ57192033
P433issue1
P921main subjectFactor V LeidenQ185986
thrombosisQ261327
venous thromboembolismQ9397786
P304page(s)17-22
P577publication date2014-12-11
P1433published inJournal of Thrombosis and HaemostasisQ6296004
P1476titleFactor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS)
P478volume13

Reverse relations

cites work (P2860)
Q92107537Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer
Q57824763Cancer-associated thrombosis: The search for the holy grail continues
Q51737961Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Q90466730Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
Q98183400Genes and proteins associated with the risk for cancer-associated thrombosis
Q40577579Genetic Risk Factors in Venous Thromboembolism.
Q37331210Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
Q47377864Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay
Q52339910Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
Q91979008Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients
Q55396746Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
Q98183396Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future
Q38944457Venous Thromboembolism in Patients Diagnosed With Lung Cancer
Q36636558Venous thrombosis and cancer: from mouse models to clinical trials.

Search more.